01537nas a2200325   4500000000100000008004100001260001600042653001000058653002200068653001100090653002700101653002500128653003300153653001100186653001200197653000900209653002100218100001500239700001200254700001300266700001400279700001600293700001700309700001100326245007600337300001100413490000600424520076700430022001401197       1979                            d  c1979 Feb 2410aAdult10aAntibodies, Viral10aFemale10aHepatitis B Antibodies10aHepatitis B Antigens10aHepatitis B Surface Antigens10aHumans10aleprosy10aMale10aRadioimmunoassay1 aChiron J P1 aDenis F1 aMaupas P1 aGoudeau A1 aCoursaget P1 aLanguillon J1 aRoux G00a[The hepatitis B virus markers, in leprous patients (author's transl)].  a659-620 v83 a<p>The hepatitis B virus markers were studied on 553 leprous sera and 100 controls sera. HBs Ag detected by RIA were present on 25,4% of leprous and 12% of controls; the anti-HBs by RIA were revealed in 44,1% of patients out 38% of controls. The leprous was not carrying this markers were HBe Ag or anti-HBe or anti-HBc positive. By this vertical study it appears that 2,4% of the cases presented recent or acute hepatitis; 23% were chronic carriers; 41,7% had been in times past infected but were cured and the third remaining had been infected but coat markers were absent, it is more than likely that is an old infected group. The study revealed no significant difference in hepatitis chronic forms frequency between lepromatous and tuberculoïd patients.</p>  a0301-1518